Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 11.04
+0.04 (0.36%)
Oct 13, 2026, 12:12 PM CET
Xspray Pharma AB Market Cap
Xspray Pharma AB has a market cap or net worth of 523.48 million as of October 12, 2026. It is the 30,089th most valuable company in the world and the 385th biggest in Sweden. Its market cap has decreased by 51.11% in one year.
Market Cap
523.48M
Enterprise Value
490.87M
Revenue
2.47M
Global Rank
Country Rank
#385 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 523.48M, an increase of 39.33%. That is a compound annual growth rate of 3.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 523.48M | -60.12% |
| Dec 30, 2025 | 1.31B | -14.72% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 975.33M |
| SynAct Pharma AB | 946.37M |
| Medivir AB | 932.31M |
| AlzeCure Pharma AB | 932.19M |
| FluoGuide | 518.27M |
| Cantargia AB | 386.26M |
| Sprint Bioscience AB | 385.13M |
| Mendus AB | 381.31M |